Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02568462
Recruitment Status : Active, not recruiting
First Posted : October 6, 2015
Last Update Posted : June 8, 2016
Information provided by (Responsible Party):
Amaranth Medical Inc.

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 2017
  Estimated Study Completion Date : July 2021
Granada JF. The Amaranth PLLA based bioresorbable scaffold (ABRS): Experimental and early human results. TCT presentation 2013.
Granada JF. BRS with clinical data III, Amaranth: Differentiating features and clinical update. TCT presentation 2014.